VRX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Valeant Pharmaceuticals International Inc's other expenses for the three months ended in Sep. 2014 was $-943 Mil. Its other expenses for the trailing twelve months (TTM) ended in Sep. 2014 was $-3,611 Mil.
Other Expenses incurred by banks.
Valeant Pharmaceuticals International Inc Other Expenses for the trailing twelve months (TTM) ended in Sep. 2014 was -860.77 (Dec. 2013 ) + -883.1 (Mar. 2014 ) + -923.4 (Jun. 2014 ) + -943.4 (Sep. 2014 ) = $-3,611 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
Valeant Pharmaceuticals International Inc Annual Data
Valeant Pharmaceuticals International Inc Quarterly Data